.After F2G's first effort to get a brand-new lesson of antifungal to market was actually hindered by...
.Moderna has promised to reduce R&D spending through $1.1 billion by 2027. The selection to retra...
.Just four months after Sanofi wager $80 thousand in beforehand money on Key Therapies' losmapimod, ...
.Cancer company Oncternal Rehabs is folding all its scientific tests as well as laying off personnel...
.Roche is holding out hopes that its injectable weight problems possibility could inevitably illustr...
.Novo Nordisk has elevated the top on a stage 1 test of its own oral amylin and GLP-1 receptor co-ag...
.Only a couple of brief weeks after gaining an FDA Fast lane tag for its investigational BTK degrade...
.Not long after a positive data drop for Eli Lilly's efsitora alfa, the Indianapolis-based provider ...
.BridgeBio Pharma is actually slashing its own genetics treatment budget as well as pulling back com...
.GSK's try to create the initial vaccination for genital herpes simplex infection (HSV) has finished...